These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 309134)

  • 41. Identification and recombinant analysis of botrocetin-2, a snake venom cofactor for von Willebrand factor-induced platelet agglutination.
    Yamamoto-Suzuki Y; Sakurai Y; Fujimura Y; Matsumoto M; Hamako J; Kokubo T; Kitagawa H; Kawsar SM; Fujii Y; Ozeki Y; Matsushita F; Matsui T
    Biochemistry; 2012 Jul; 51(26):5329-38. PubMed ID: 22647083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage.
    Rucavado A; Soto M; Kamiguti AS; Theakston RD; Fox JW; Escalante T; Gutiérrez JM
    Thromb Haemost; 2001 Apr; 85(4):710-5. PubMed ID: 11341509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphological studies of platelet aggregates induced by human von Willebrand factor in platelet-type von Willebrand's disease.
    Takahashi H; Hattori A; Nagayama R; Hanano M; Fuse I; Takizawa S; Takeshige T; Shibata A
    Thromb Res; 1985 May; 38(4):433-8. PubMed ID: 3874446
    [No Abstract]   [Full Text] [Related]  

  • 44. Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays.
    Brinkhous KM; Read MS
    Thromb Res; 1978 Oct; 13(4):591-7. PubMed ID: 311530
    [No Abstract]   [Full Text] [Related]  

  • 45. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis.
    Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L
    Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
    Hill-Eubanks DC; Parker CG; Lollar P
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma cofactors necessary for Enhydrina schistosa (beaked sea snake) venom to induce platelet aggregation.
    Marshall LR; Herrmann RP
    Thromb Res; 1986 Jul; 43(2):229-35. PubMed ID: 3738863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Culture-produced subendothelium. II. Effect of plasma, F.VIIIR:WF and fibronectin on interaction of normal platelets with normal and von Willebrand porcine aortic subendothelium.
    Booyse FM; Feder S; Quarfoot AJ
    Thromb Res; 1982 Nov; 28(3):299-311. PubMed ID: 6817457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasma levels of platelet aggregating factor/vom Willebrand factor in various species.
    Brinkhous KM; Thomas BD; Ibrahim SA; Read MS
    Thromb Res; 1977 Sep; 11(3):345-55. PubMed ID: 411191
    [No Abstract]   [Full Text] [Related]  

  • 51. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
    Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
    Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
    Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
    Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study of platelet aggregation and secretion induced by Bothrops jararaca snake venom and thrombin.
    Rosa JG; de Albuquerque CZ; Mattaraia VGM; Santoro ML
    Toxicon; 2019 Mar; 159():50-60. PubMed ID: 30677414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vancomycin as well as ristocetin facilitates von Willebrand factor binding to platelets.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jul 1-15; 19(1-2):287-92. PubMed ID: 6969463
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed platelets.
    Kelton JG; Bishop J; Carter CJ; Hirsh J
    Thromb Res; 1980 May 1-15; 18(3-4):477-83. PubMed ID: 6968105
    [No Abstract]   [Full Text] [Related]  

  • 60. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.